Draegerwerk AG & Co KGaA (DRWKF) (Q2 2026) Earnings Call Highlights: EBIT More Than ...

This article first appeared on GuruFocus .

Release Date: July 30, 2026

For the complete transcript of the earnings call, please refer to the full earnings call transcript .

Positive Points

• Net sales grew by 7.7% in the first half of 2026, driven by strong demand across most regions.

• EBIT more than tripled to around 64 million, lifting the EBIT margin to 4.0% from 1.3%.

• Free cash flow improved significantly to around 16 million from minus 42 million in the prior year.

• Safety division saw strong order intake growth of 9.5% and EBIT margin rose to 11%.

• Guidance raised twice, with EBIT margin now expected between 6% and 8% for full year 2026.

Negative Points

• Medical division order intake declined 3.7% due to a major prior-year order from Mexico.

• Functional expenses rose by 8% in Q2, driven by higher personnel costs and freight rates.

• Geopolitical tensions in the Middle East increased logistics costs, with an expected impact of up to 10 million.

• Medical division EBIT remained negative at minus 14.3 million for the first half.

• Demand for anesthesia machines and ventilators declined in the medical division.

Q & A Highlights

• Warning! GuruFocus has detected 3 Warning Signs with STU:WIS.

• Is DRWKF fairly valued? Test your thesis with our free DCF calculator.

Q: Oliver Reinberg (Kepler Schere) asked about the sustainability of the strong performance in the Safety division, questioning if the current margin is at a peak or if there is further expansion potential. A: Stefan Prager (CEO) stated that the development in Safety is sustainable, driven by solid markets like defense, though the chemical industry is slightly weak. He does not view the current margin as a peak and expects further expansion, with more details to be discussed at the Capital Markets Day in November.

Q: Oliver Reinberg asked about the impact of geopolitical challenges on cost inflation, specifically regarding logistics and freight costs. A: Stefan Prager (CEO) noted that the blocking of the Strait of Hormuz and the Iran conflict have led to higher logistics costs in air and sea freight, with an expected impact of up to 10 million for the full year 2026. He also mentioned a slight reduction in top-line business in the region due to travel difficulties, but emphasized the overall effect is relatively small compared to the company's total size.

Q: Oliver Reinberg inquired about the decline in order intake for medical therapy devices, specifically anesthesia machines and ventilators, and whether competitor actions (e.g., GE's new anesthesia device) or market changes are affecting demand. A: Stefan Prager (CEO) responded that the medical division's profitability is expected to develop even faster in the near to mid-term, narrowing the gap with Safety. He highlighted that the environmental markets remain intact, and the company's focus on service-oriented device connectivity and automation is well-received by customers, particularly in times of personnel shortages.